AlphaCore Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
15,285
-832
-5% -$74.2K 0.03% 324
2025
Q4
$1.27M Buy
16,117
+6,507
+68% +$510K 0.03% 353
2025
Q3
$768K Buy
9,610
+1,104
+13% +$94.2K 0.03% 358
2025
Q2
$773K Buy
8,506
+1,587
+23% +$145K 0.03% 298
2025
Q1
$648K Buy
6,919
+2,511
+57% +$225K 0.06% 232
2024
Q4
$401K Sell
4,408
-46
-1% -$4.39K 0.09% 140
2024
Q3
$462K Buy
4,454
+800
+22% +$81.5K 0.1% 118
2024
Q2
$355K Sell
3,654
-287
-7% -$26.5K 0.09% 132
2024
Q1
$355K Buy
3,941
+72
+2% +$6.1K 0.09% 116
2023
Q4
$308K Sell
3,869
-151
-4% -$11.4K 0.05% 188
2023
Q3
$286K Buy
4,020
+100
+3% +$7.48K 0.05% 187
2023
Q2
$302K Buy
3,920
+50
+1% +$3.87K 0.05% 174
2023
Q1
$291K Buy
3,870
+50
+1% +$3.72K 0.08% 110
2022
Q4
$301K Hold
3,820
0.12% 60
2022
Q3
$268K Buy
3,820
+1,025
+37% +$80.4K 0.12% 55
2022
Q2
$224K Buy
+2,795
New +$219K 0.1% 63

Other funds holding CL

AlphaCore Capital's CL Position: Q1 2026 in Review

AlphaCore Capital reduced its Colgate-Palmolive (CL) stake by 5.2% in Q1 2026, selling an estimated $74.2K and leaving 15,285 shares worth $1.3M. The position accounts for 0.03% of the portfolio, ranked #324.

AlphaCore Capital first reported a position in CL in Q2 2022 and has held it in 16 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • AlphaCore Capital held 15,285 shares of Colgate-Palmolive worth $1.3M as of Q1 2026.
  • AlphaCore Capital sold 832 Colgate-Palmolive shares in Q1 2026, an estimated $74.2K.
  • Colgate-Palmolive made up 0.03% of AlphaCore Capital's portfolio in Q1 2026, its #324 holding.
  • AlphaCore Capital first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 16 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.